Different lifestyles have an impact on useful metabolic functions, causing disorders. Different
lipids are involved in the metabolic functions that play various vital roles in the body, such as …

Abstract The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or
statins, are administered as first line therapy for hypercholesterolemia, both in primary and …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

The lipid profile, which is routinely done to assess a cardiovascular risk, involves the
measurement/calculation of serum/plasma levels of total cholesterol (TC), high-density …

Atherosclerosis is a multifactorial vascular disease that leads to inflammation and stiffening
of the arteries and decreases their elasticity due to the accumulation of calcium, small dense …

Hypertriglyceridemia is associated with increased cardiovascular disease (CVD) risk. The
Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) …

Circulating concentration and activity of secretory phospholipase A 2 (sPLA 2) and
lipoprotein-associated phospholipase A 2 (Lp-PLA 2) have been proven as biomarkers of …

Results The LIPIDOGRAM2015 and LIPIDOGEN2015 study cohort reflects the prevalence of
cardiovascular risk factors and concomitant diseases, markers of oxidative stress, the …

Background Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive
disorder characterized by persistent extreme hypertriglyceridemia as a result of lipoprotein …

Pomimo upływu pięciu lat od publikacji ostatnich wytycznych zaburzenia przemiany lipidów
są wciąż najbardziej rozpowszechnionym i najgorzej kontrolowanym czynnikiem ryzyka …